Biolife Solutions Inc (BLFS) Company Profile & Statistics

Biolife Solutions Inc
BLFS
(Nasdaq - US)
N/A
18.15
+0.67 (+3.83%)
in:usd•As of: May 02, 2024 15:59 UTC -4
Open
17.66
High
18.33
Low
17.37

About Biolife Solutions Inc

CEO

Roderick de Greef

Headquarters

3303 monte villa parkway, suite 310

bothell, wa 98021, united states

Auditor

GRANT THORNTON LLP

Employees

414

Share Holders

256

Website

www.biolifesolutions.com

Industry

medical specialties

Sector

health technology

Company Overview

BioLife Solutions has pioneered the next generation of preservation solutions designed to maintain the viability and health of cellular matter and tissues during freezing, transportation and storage. Based on their proprietary bio-packaging technology and a patented understanding of the mechanism of cellular damage and death, these products enable the biotechnology and medical community to address a growing problem that exists today.

Biolife Solutions Inc Statistics

Valuation Measures

Market Capitalization ²	822.19M
Enterprise Value	813.45M
Enterprise Value/EBITDA (ttm)	-13.90
Price to Earnings Ratio (ttm)	N/A
Price to Book (mrq)	2.29
Price to Sales (ttm)	5.55
Price to Cash (ytd)	N/A

Profitability

Gross Margin (ttm)	32.59%
Operating Margin (ttm)	-32.18%
Profit Margin (ttm)	-47.62%
Return on Equity (ttm)	-13.36%
Return on Invested Capital (ttm)	-18.27%
Return on Assets (ttm)	-10.83%

Income Statement

Revenue (ttm)	143.27M
Revenue Per Share (ttm)	3.16
Gross Profit (ttm)	46.75M
EBITDA (ttm)³	-58.52M
Net Income Avi to Common (ttm)	-66.43M
Diluted EPS (ttm)	-1.52

Share Statistics

Beta (5Y Monthly)	1.69
52-Week Change	5.58%
S&P500 52-Week Change	24.86%
S&P500 Member	No
Stock Optionable	Yes
Total Shares Outstanding ¹	45.30M
Dividend Yield	0.00%
Float ⁴	44.08M
% Held by Insiders	2.70%
% Held by Institutions	93.24%

Balance Sheet

Total Cash (mrq)	51.73M
Total Cash Per Share (mrq)	1.14
Total Debt (mrq)	26.69M
Total Debt/Equity (mrq)	7.90%
Current Ratio (mrq)	2.86%
Quick Ratio (mrq)	1.83%
Book Value Per Share (mrq)	7.48

Cash Flow

Operating Cash Flow Per Share (ytd)	-0.29
Free Cash Flow (ytd)	-18.88M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. Stock price provided by Xignite. All numbers are rounded to the closest decimal.

¹ Total Shares outstanding is taken from the most recently filed quarterly or annual report.

² Market Cap is calculated using total shares outstanding and the most recent share price.

³ EBITDA is calculated using methodology that may differ from that used by a company in its reporting.

⁴ The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

Biolife Solutions Inc

Trade With A Regulated Broker